BSE - Delayed Quote INR

Lykis Limited (LYKISLTD.BO)

40.90
+2.56
+(6.68%)
At close: May 23 at 3:29:51 PM GMT+5:30
Loading Chart for LYKISLTD.BO
  • Previous Close 38.34
  • Open 39.00
  • Bid 40.30 x --
  • Ask 40.74 x --
  • Day's Range 38.00 - 41.70
  • 52 Week Range 25.30 - 53.99
  • Volume 16,001
  • Avg. Volume 17,424
  • Market Cap (intraday) 792.446M
  • Beta (5Y Monthly) -0.49
  • PE Ratio (TTM) 31.46
  • EPS (TTM) 1.30
  • Earnings Date Jul 28, 2025 - Aug 1, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand wash; hair care products comprising shampoo, spray, conditioner, base cream, hair food and relaxer, oil, detox mask, cleansing liquid, hair colour and milk, pomade, and gels; toothpaste; soaps; deodorant, perfume, and body mist; and baby cream, oil, shampoo, talc, wipes, and diaper. It also offers FMCG products, including biscuits and cookies; confectionery, such as candy, lollipops, and toffees; commodity products comprising hot pots, stock pots, utensils, footwear, liquor, and others; and other OTC products. The company provides its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, Calmon, Bon Dejeuner, Mellar, Bom Dia, Blue Fins, Bon Appetit, Senhorita, Polo Star, Leopard, Elephant, Carnoba, Classic, Maria, Spectra, Flite, Bahamas, Sparx, Metro, Cipro, Para, Dextrose and Water for Injection, Davigra, Dermogerme, A-DEM, Candicyl, Rectostop-HC, Nystatine, and Davimov brands. It also exports its products. Lykis Limited was formerly known as Greenline Tea & Exports Limited and changed its name to Lykis Limited in July 2012. The company was incorporated in 1984 and is headquartered in Mumbai, India.

www.lykis.com

80

Full Time Employees

March 31

Fiscal Year Ends

Recent News: LYKISLTD.BO

View More

Performance Overview: LYKISLTD.BO

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

LYKISLTD.BO
5.74%
S&P BSE SENSEX (^BSESN)
4.58%

1-Year Return

LYKISLTD.BO
7.05%
S&P BSE SENSEX (^BSESN)
8.36%

3-Year Return

LYKISLTD.BO
7.05%
S&P BSE SENSEX (^BSESN)
50.53%

5-Year Return

LYKISLTD.BO
7.05%
S&P BSE SENSEX (^BSESN)
166.43%

Compare To: LYKISLTD.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LYKISLTD.BO

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    789.34M

  • Enterprise Value

    1.50B

  • Trailing P/E

    31.34

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.23

  • Price/Book (mrq)

    2.38

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    16.04

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.71%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.56B

  • Net Income Avi to Common (ttm)

    25.21M

  • Diluted EPS (ttm)

    1.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    56.95M

  • Total Debt/Equity (mrq)

    250.59%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LYKISLTD.BO

View More

Company Insights: LYKISLTD.BO

Research Reports: LYKISLTD.BO

View More

People Also Watch